Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-10-05
1995-03-07
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514422, 514383, 514397, 514407, 514343, 514340, 514341, 514290, 514314, 5482654, 5483111, 5483124, 5483137, 5483147, 5483641, 5483651, 548492, 548524, 546276, 546278, 546279, 546281, 546101, 546169, 546175, A61k 3140, A61k 3144, C07D20910, C07D20750, C07D40108, C07D23358
Patent
active
053958497
ABSTRACT:
The present invention provides novel antitumor agents which are hybrid molecules consisting of a cyclic enediyne unit attached to a DNA-binding unit via a linker unit, and having the general formula (I)
REFERENCES:
D. L. Boger and J. Zhou, "CDPI.sub.3 -Enediyne and CDP1.sub.3 -EDTA Conjugates: A New Class of DNA Cleaving Agents", Journal of Organic Chemistry, 58, pp. 3018-3024, 1993.
K. C. Nicolaou, et al, "Chemistry and Biology of Natural and Designed Enediynes", Proceedings of the National Academy of Sciences, USA, 90, pp. 5881-5888, 1993.
K. C. Nicolaou and W. M. Dai, "Chemistry and Biology of the Enediyne Anticancer Antibiotics", Angewandte Chemie, 30, No. 11, pp. 1387-1416, 1991.
Masahiko Tokuda, et al, "Synthesis of a Hybrid Molecule Containing Neocarzinostatin Chromophore Analogue and Minor Groove Binder", Tetrahedron Letters, 34, No. 4, pp. 669-672, 1993.
K. Toshima, et al, "Design, Synthesis and DNA Cleaving Profiles of Hybrids Containing the Novel Enediyne and Naturally Occurring DNA Intercalators", Journal of the Chemical Society, Chemical Communications, USA, pp. 1525-1527, 1993.
Kadow John F.
Langley David
Wittman Mark D.
Bristol--Myers Squibb Company
Han Willaim T.
Lee Mary C.
McKane Joseph K.
LandOfFree
Hybrid antitumor compounds containing a cyclic enediyne and a DN does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hybrid antitumor compounds containing a cyclic enediyne and a DN, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hybrid antitumor compounds containing a cyclic enediyne and a DN will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1406193